Adi Mor
Chief Executive Officer presso CHEMOMAB THERAPEUTICS LTD.
Patrimonio netto: 22 132 $ in data 31/03/2024
Profilo
Adi Mor is the founder.
She founded Chemomab Ltd.
in 2011, where she holds the title of Director, Chief Executive & Scientific Officer.
She also founded Chemomab Therapeutics Ltd.
in 2011, where she holds the title of Chief Executive Officer & Director.
Dr. Mor obtained a doctorate degree from Tel-Aviv University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
28/03/2024 | 568 222 ( 0.27% ) | 22 132 $ | 31/03/2024 |
Posizioni attive di Adi Mor
Società | Posizione | Inizio |
---|---|---|
CHEMOMAB THERAPEUTICS LTD. | Chief Executive Officer | 01/06/2023 |
Chemomab Ltd.
Chemomab Ltd. BiotechnologyHealth Technology ChemomAb Ltd. develops novel chemokine blocking therapies for inflammatory and fibrotic disorders. It specializes in the development of proprietary monoclonal antibodies, directed towards novel targets, for the treatment of immune-mediated and fibrotic disorders including orphan indications. The company was founded by Adi Mor and Jacob George in 2011 and is headquartered Tel Aviv, Israel. | Chief Executive Officer | 01/01/2011 |
Formazione di Adi Mor
Tel-Aviv University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Chemomab Ltd.
Chemomab Ltd. BiotechnologyHealth Technology ChemomAb Ltd. develops novel chemokine blocking therapies for inflammatory and fibrotic disorders. It specializes in the development of proprietary monoclonal antibodies, directed towards novel targets, for the treatment of immune-mediated and fibrotic disorders including orphan indications. The company was founded by Adi Mor and Jacob George in 2011 and is headquartered Tel Aviv, Israel. | Health Technology |
Chemomab Therapeutics Ltd. |
- Borsa valori
- Insiders
- Adi Mor